Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ivan S. Pires"'
Autor:
Carlos J. Munoz, Daniela Lucas, Jacinda Martinez, Mia Ricario, Quintin T. O'Boyle, Ivan S. Pires, Andre F. Palmer, Pedro Cabrales
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 174, Iss , Pp 116569- (2024)
Alpha-alpha diaspirin-crosslinked human hemoglobin (DCLHb or ααHb) was a promising early generation red blood cell (RBC) substitute. The DCLHb was developed through a collaborative effort between the United States Army and Baxter Healthcare. The co
Externí odkaz:
https://doaj.org/article/56fb0c0c15a04929bbd507e481d79631
Autor:
Stephanie Kong, Pearl Moharil, Abram Handly‐Santana, Natalie Boehnke, Richard Panayiotou, Victoria Gomerdinger, Gil Covarrubias, Ivan S. Pires, Ioannis Zervantonakis, Joan Brugge, Paula T. Hammond
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 2, Pp n/a-n/a (2023)
Abstract The majority of patients with high grade serous ovarian cancer (HGSOC) develop recurrent disease and chemotherapy resistance. To identify drug combinations that would be effective in treatment of chemotherapy resistant disease, we examined t
Externí odkaz:
https://doaj.org/article/0fdb0c64b4324a05901ffd1980280b58
Autor:
Antonio E. Barberio, Sean G. Smith, Ivan S. Pires, Sonia Iyer, Ferenc Reinhardt, Mariane B. Melo, Heikyung Suh, Robert A. Weinberg, Darrell J. Irvine, Paula T. Hammond
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 2, Pp n/a-n/a (2023)
Abstract Ovarian cancer is especially deadly, challenging to treat, and has proven refractory to known immunotherapies. Cytokine therapy is an attractive strategy to drive a proinflammatory immune response in immunologically cold tumors such as many
Externí odkaz:
https://doaj.org/article/da7a5559c1a94ad19eb3527ed8b1cd25
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 156, Iss , Pp 113911- (2022)
β-thalassemia is a genetic hemoglobin (Hb) disorder that affects millions of people world-wide. It is characterized by ineffective erythropoiesis and anemia. The resultant chronic anemia can require life-long blood transfusion regimens, leading to s
Externí odkaz:
https://doaj.org/article/de54c08cc9264bf6be40b1ef68b4eed6
Autor:
Yanpu He, Celestine Hong, Shengnan Huang, Justin A. Kaskow, Gil Covarrubias, Ivan S. Pires, James C. Sacane, Paula T. Hammond, Angela M. Belcher
Publikováno v:
Advanced Healthcare Materials.
Autor:
Antonio E. Barberio, Sean G. Smith, Ivan S. Pires, Sonia Iyer, Ferenc Reinhardt, Mariane B. Melo, Heikyung Suh, Robert A. Weinberg, Darrell J. Irvine, Paula T. Hammond
Publikováno v:
Bioengineering & Translational Medicine. 8
Autor:
Stephanie Kong, Pearl Moharil, Abram Handly‐Santana, Natalie Boehnke, Richard Panayiotou, Victoria Gomerdinger, Gil Covarrubias, Ivan S. Pires, Ioannis Zervantonakis, Joan Brugge, Paula T. Hammond
Publikováno v:
Bioengineering & Translational Medicine. 8
Autor:
null Antonio E. Barberio, null Sean G. Smith, null Ivan S. Pires, null Sonia Iyer, null Ferenc Reinhardt, null Mariane B. Melo, null Heikyung Suh, null Robert A. Weinberg, null Darrell J. Irvine, null Paula T. Hammond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495ca6d0885719d6dd688e70d2ee213f
https://doi.org/10.1002/btm2.10453/v3/response1
https://doi.org/10.1002/btm2.10453/v3/response1
Autor:
Ivan S. Pires, Kaiyuan Ni, Mariane Bandeira Melo, Na Li, Elana Ben-Akiva, Laura Maiorino, Jonathan Dye, Kristen A. Rodrigues, DongSoo Yun, Byungji Kim, Ryan R. Hosn, Paula T. Hammond, Darrell J. Irvine
Publikováno v:
Chemical Engineering Journal. 464:142664
Autor:
Andre F. Palmer, Xiangming Gu, Donald A. Belcher, Ivan S. Pires, Chintan Savla, Crystal Bolden-Rush, Clayton T. Cuddington
Publikováno v:
Biotechnol Bioeng
Previously, our lab developed high molecular weight (MW) tense (T) quaternary state glutaraldehyde polymerized bovine hemoglobins (PolybHbs) that exhibited reduced vasoactivity in several small animal models. In this work, we prepared PolybHb in the